Evidence map›Paper›PMID 37956212›Full record

ArticlePLoS computational biology2023

A general hypergraph learning algorithm for drug multi-task predictions in micro-to-macro biomedical networks.

Shuting Jin, Yue Hong, Li Zeng, Yinghui Jiang, Yuan Lin, Leyi Wei, Zhuohang Yu, Xiangxiang Zeng, Xiangrong Liu

Abstract read
In one paragraph

Article in PLoS computational biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. HANSynergy: Heterogeneous Graph Attention Network for Drug Synergy Prediction.Journal of chemical information and modeling · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shuting JinSchool of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, China.ORCID 0000-0002-8113-9367
Yue HongSchool of Informatics, Xiamen University, Xiamen, China.
Li ZengDepartment of AIDD, Shanghai Yuyao Biotechnology Co., Ltd., Shanghai, China.
Yinghui JiangSchool of Informatics, Xiamen University, Xiamen, China.
Yuan LinSchool of Economics, Innovation, and Technology, Kristiania University College, Bergen, Norway.
Leyi WeiSchool of Software, Shandong University, Shandong, China.
Zhuohang YuShanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, School of Pharmacy, East China University of Science and Technology, Shanghai, China.
Xiangxiang ZengSchool of Information Science and Engineering, Hunan University, Hunan, China.ORCID 0000-0003-1081-7658
Xiangrong LiuSchool of Informatics, Xiamen University, Xiamen, China.ORCID 0000-0001-9885-1978

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The powerful combination of large-scale drug-related interaction networks and deep learning provides new opportunities for accelerating the process of drug discovery. However, chemical structures that play an important role in drug properties and high-order relations that involve a greater number of nodes are not tackled in current biomedical networks. In this study, we present a general hypergraph learning framework, which introduces Drug-Substructures relationship into Molecular interaction Networks to construct the micro-to-macro drug centric heterogeneous network (DSMN), and develop a multi-branches HyperGraph learning model, called HGDrug, for Drug multi-task predictions. HGDrug achieves highly accurate and robust predictions on 4 benchmark tasks (drug-drug, drug-target, drug-disease, and drug-side-effect interactions), outperforming 8 state-of-the-art task specific models and 6 general-purpose conventional models. Experiments analysis verifies the effectiveness and rationality of the HGDrug model architecture as well as the multi-branches setup, and demonstrates that HGDrug is able to capture the relations between drugs associated with the same functional groups. In addition, our proposed drug-substructure interaction networks can help improve the performance of existing network models for drug-related prediction tasks.

Indexed as

AlgorithmsDrug-Related Side Effects and Adverse ReactionsBenchmarkingDrug Delivery SystemsDrug DiscoveryHumans

Identifiers

PMID37956212
PMCPMC10681315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.